Reuters: Regulatory News: UPDATE 1-Abiomed's heart pump gets EU nod

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Abiomed's heart pump gets EU nod Apr 12th 2012, 12:40 April 12 | Thu Apr 12, 2012 8:40am EDT April 12 (Reuters) - Abiomed Inc said European health regulators approved the use of its heart pump in cardiac surgery. The Danvers, Massachusetts-based company said the device, called Impella cVAD, is expected to be commercially available in Europe by this summer. The device is intended for use in cardiac surgery for supporting the weakened heart's left ventricle, which is responsible for pumping oxygen-rich blood from the lungs throughout the body. Impella cVAD is still not approved in the United States. Abiomed shares closed at $20.90 on Wednesday on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions